Continuous Selective Intra-Arterial Application of Nimodipine in Refractory Cerebral Vasospasm due to Aneurysmal Subarachnoid Hemorrhage

Table 2

rCBF before, at 2 and 6 hours, and 1–5 days after starting continuous selective intra-arterial nimodipine infusion, rCBF (mL/100 g/min).

Case no.	rCBF before	rCBF at 2 hours	rCBF at 6 hours	rCBF day 1	rCBF day 2	rCBF day 3	rCBF day 4	rCBF day 5
1	14	22	24	23.3	17.6	9.5	6.3	0
2	17	61	66	44.7	34.8	24.3	7.3	4.2
3	17	46	48	47.3	45.8	36.3	37.5	0
4	16	61	63	50.1	44.4	0	0	0
5	19	58	54	45.6	38.3	33.7	35.1	0
6	12	38	34	33.1	28.4	19.0	0	0
7	13	46	46	43.8	36.2	33.4	0	0
8	12	49	44	23.0	19.3	12.5	0	0
9	17	47	50	48.7	43.9	38.3	0	0
10	16	23	25	22.3	14.5	0	0	0
11	16	73	68	53.8	49.7	45.7	0	0
12	14	24	20	23.7	22.6	12.2	9.3	0
13	12	40	33	30.4	24.0	22.2	0	0
16	15	53	54	45.3	39.3	37.2	0	0
18	8	57	50	38.4	30.6	20.4	0	0
21	12	46	44	29.6	22.9	17.5	0	0
22	7	40	39	35.2	33.8	0	0	0
23	15	55	51	44.8	41.6	37.9	33.9	35.6
24	16	60	54	46.2	42.9	26.7	0	0
27	14	43	44	36.2	22.3	0	0	0
28	12	45	43	36.7	36.8	39.4	0	0
29	9	24	34	23.0	15.7	13.5	0	0

rCBF: regional cerebral blood flow; 0: no continuous selective intra-arterial nimodipine application.